MIAMI, Sept 17, 2018 (GLOBE NEWSWIRE) – World Technology Corp. (OTC: WCOR) (“World Technology” or the “Company”), a technology company that leverages its Life Sensing Technology to promote wellness worldwide using its Helo branded wearable devices, today announced that its Helo Extense device, a portable, stand-alone device that is capable of non-invasively measuring the user’s blood sugar trend conveniently and on demand, has received CE Class 1 Medical Device Certification (the “Certification”) from the Ministry of Health in Italy. The Certification confirms that the Helo Extense device is considered safe and a low-risk device when used as intended. The Company is in the process of completing certification of Helo Extense’s measurement function and anticipates attaining this certification during the fourth quarter of 2018.
“The Certification is an important milestone for our Company,” commented Sean McVeigh, Chief Executive Officer of World Technology. ”We believe that receipt of the Certification demonstrates our commitment and ability to develop quality products that promote wellness. We believe this Certification, together with certification of Helo Extense’s measurement function will not only enhance the credibility of our Helo products in our current self-monitoring wellness market, but will also pave the way for us to enter the healthcare market, once we secure appropriate approvals.”
“On the strategic front, we believe that we are making progress with our plan to expand our product offerings and revenue base, and we are continuing to pursue an up-listing of our common stock to Nasdaq,” continued Mr. McVeigh.
About World Technology Corp.
We are a technology, wearable device, and data company with an open platform enabling the conversion of wearer data into actionable wearer information. We embed our Life Sensing Technology into our innovative, connected, wearable devices. Our Life Sensing Technology uses state-of-the-art sensors, enhanced signal processing, and algorithms to collect and process specific data from our device wearers. Our database contains extensive multi-ethnic, biometric and vital sign data that not only informs our in-house development but also has the potential to develop into a diverse and rich resource for wellness and health-related data mining and third-party software application development. We continuously gather data from our wearers in an effort to build an anonymized database that may enable our partners to determine new insights, identify new trends generated from our wearer data and offer our wearers information-based solutions based on our platform. For further information, see www.worldcorp.com
This news release contains “forward-looking statements” within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended, and as defined in the U.S. Private Securities Litigation Reform Act of 1995. These forward-looking statements can be identified by terminology such as “may,” “will,” “expects,” “anticipates,” “future,” “intends,” “plans,” “believes,” “estimates,” “potential” and similar statements. All statements other than statements of historical fact in this press release are forward-looking statements and involve certain risks and uncertainties that could cause actual results to differ materially from those in the forward-looking statements. These forward-looking statements are based on management’s current expectations, assumptions, estimates and projections about the Company and the industry in which the Company operates, but involve a number of unknown risks and uncertainties. Further information regarding these and other risks is included in the Company’s filings with the OTC Markets and the Securities and Exchange Commission. The Company undertakes no obligation to update forward-looking statements to reflect subsequent occurring events or circumstances, or changes in its expectations, except as may be required by law. Although the Company believes that the expectations expressed in these forward-looking statements are reasonable, it cannot assure you that such expectations will turn out to be correct, and actual results may differ materially from the anticipated results. You are urged to consider these factors carefully in evaluating the forward-looking statements contained herein and are cautioned not to place undue reliance on such forward-looking statements, which are qualified in their entirety by these cautionary statements.
At the Company:
Sean McVeigh, CEO